December 26, 2024

Study Links Dopamine Dysregulation to Chronic Pain

New research uncovers how the loss of JMJD3, a key histone demethylase, disrupts dopamine production and amplifies chronic inflammatory pain in mice, offering insights into potential therapeutic targets.

Conexiant

December 19, 2024

How Copper Accumulation Impacts the Liver

From early inflammation to advanced fibrosis, researchers detail the liver damage caused by copper overload and the role of treatment.

Conexiant

December 18, 2024

Understanding the 2022 WHO Classification of Endocrine Tumors

From the parathyroid to adrenal glands and thyroid tumors, the latest WHO classification introduces essential updates to tumor nomenclature and diagnostic criteria.

Conexiant

September 30, 2024

New DNA Test Accurately Differentiates Between Thymic Tumors

Misdiagnosis can lead to inappropriate treatment, potentially subjecting patients to unnecessary toxicity or, conversely, inadequate treatment for a life-threatening cancer.

Conexiant

October 30, 2024

Study Identifies RUNX1 as a Major Therapeutic Target in Acute Kidney Injury

Targeting the RUNX1 pathway may reduce inflammation and improve kidney function in patients with acute kidney injury, potentially preventing the disease from progressing to chronic kidney failure.

Conexiant

November 01, 2024

Could Targeting CD44 Help Prevent Obesity? New Findings Show Promising Results

Researchers find that suppressing CD44 can inhibit fat cell growth, offering insights for future obesity treatments.

Conexiant

December 03, 2024

Gluten-Free Diet Restores Key Epigenetic Marker in Coeliac Disease

LINE-1 hypomethylation, a reversible feature of Coeliac disease inflammation, offers new insights into cancer prevention.

Conexiant